BusinessPetLife Pharmaceuticals Announces Son of World Famous Veterinarian & Pet Industry Innovator, Geoffrey Broderick, to Join the Company as the New PresidentBy Nasdaq OMXFeb 3, 2017, 1:00 PM UTC
BusinessPetLife Pharmaceuticals reports the First of Three Preclinical Studies in their pre-INAD Process for Vitalzul. Blue Scorpion Venom Toxicity Study Results Show No Adverse Reactions across Multiple Dosing Levels.By Nasdaq OMXJan 10, 2017, 1:00 PM UTC
BusinessMarij Pharmaceuticals, Inc. (“MariJ” or the “Company”), a wholly-owned subsidiary of Acacia Diversified Holdings, Inc. (“Acacia”) (OTCQB symbol: ACCA), begins manufacturing USDA Certified Organic hemp oil.By Nasdaq OMXDec 29, 2016, 5:30 PM UTC
BusinessAXIM® Biotech Expands Advisory Board to Broaden the Development of Cannabinoids' Therapeutic IndicationsBy Nasdaq OMXDec 29, 2016, 2:00 PM UTC
BusinessAXIM® Biotech Expands Advisory Board With Psychiatry Specialist – Dr. Ilya ReznikBy Nasdaq OMXDec 13, 2016, 2:00 PM UTC
BusinessCorrection: PetLife Pharmaceuticals Enters Negotiations with Key Founders of InnoVision Therapeutics to Discuss Expansion of its Core Product LineBy Nasdaq OMXDec 7, 2016, 1:50 PM UTC
BusinessPetLife Pharmaceuticals Enters Negotiations with Key Founders of InnoVision Therapeutics to Discuss Expansion of its Core Product LineBy Nasdaq OMXDec 7, 2016, 1:00 PM UTC
